BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19290991)

  • 21. Nephrogenic systemic fibrosis: a review of the new conundrum.
    Goenka AH; Das CJ; Sharma R
    Natl Med J India; 2009; 22(6):302-6. PubMed ID: 20384019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
    Abraham JL; Edward M
    AJR Am J Roentgenol; 2009 Oct; 193(4):W354; author reply W355. PubMed ID: 19770307
    [No Abstract]   [Full Text] [Related]  

  • 23. Gadolinium-induced nephrogenic systemic fibrosis.
    Hellman RN
    Semin Nephrol; 2011 May; 31(3):310-6. PubMed ID: 21784280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
    Idée JM; Port M; Dencausse A; Lancelot E; Corot C
    Radiol Clin North Am; 2009 Sep; 47(5):855-69, vii. PubMed ID: 19744600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrogenic systemic fibrosis: histology and gadolinium detection.
    Thakral C; Abraham JL
    Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
    Thomsen HS
    Radiol Clin North Am; 2009 Sep; 47(5):871-5, vii. PubMed ID: 19744601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: does a US Food and Drug Administration alert influence practice patterns in CKD?
    Martin DR
    Am J Kidney Dis; 2010 Sep; 56(3):427-30. PubMed ID: 20728788
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal failure and gadolinium. The number of documented cases is rising.
    Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19537311
    [No Abstract]   [Full Text] [Related]  

  • 29. Correction to the relative risk calculation for gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis.
    Jain R; Levine M
    Radiology; 2010 Apr; 255(1):307-8; author reply 308. PubMed ID: 20308469
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nephrogenic systemic fibrosis and gadolinium contrast agents].
    Aguilera C; Agustí A
    Med Clin (Barc); 2011 May; 136(14):643-5. PubMed ID: 21397280
    [No Abstract]   [Full Text] [Related]  

  • 31. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
    Foss C; Smith JK; Ortiz L; Hanevold C; Davis L
    Pediatr Dermatol; 2009; 26(5):579-82. PubMed ID: 19840315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid.
    Nazarian RM; Mandal RV; Kagan A; Kay J; Duncan LM
    J Am Acad Dermatol; 2011 Apr; 64(4):741-7. PubMed ID: 21414498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nephrogenic systemic fibrosis: clinical picture and treatment.
    Marckmann P; Skov L
    Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrogenic systemic fibrosis and the role of gadolinium contrast media.
    van der Molen AJ
    J Med Imaging Radiat Oncol; 2008 Aug; 52(4):339-50. PubMed ID: 18811757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium - 1997-2006-2016. Part 1.
    Thomsen HS
    Acta Radiol; 2016 May; 57(5):515-20. PubMed ID: 26802069
    [No Abstract]   [Full Text] [Related]  

  • 36. Can gadolinium be given safely to a patient on dialysis?
    Rodby RA
    Semin Dial; 2011; 24(4):370-1. PubMed ID: 21801214
    [No Abstract]   [Full Text] [Related]  

  • 37. [Nephrogenic systemic fibrosis and use of MR contrast media].
    Christiansen RE; Sviland L; Sekse I; Svarstad E
    Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on nephrogenic systemic fibrosis.
    Thomsen HS; Marckmann P; Logager VB
    Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):551-60, vii. PubMed ID: 18926421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-induced nephropathy and nephrogenic systemic fibrosis. Preface.
    Morcos SK
    Radiol Clin North Am; 2009 Sep; 47(5):xi. PubMed ID: 19744592
    [No Abstract]   [Full Text] [Related]  

  • 40. Administration of gadolinium-based contrast agents in MR angiography.
    Lin K
    AJR Am J Roentgenol; 2009 Apr; 192(4):W193; author reply W194. PubMed ID: 19304680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.